Suppl_stat_methods_ID_TAM-19-09-430_R1 – Supplemental material for Effectiveness of bevacizumab in first- and second-line treatment for metastatic colorectal cancer: ITACa randomized trial

Petracci, Elisabetta; Scarpi, Emanuela; Passardi, Alessandro; Biggeri, Annibale; Milandri, Carlo; Vecchia, Stefano; Gelsomino, Fabio; Tassinari, Davide; Tamberi, Stefano; Bernardini, Ilaria; Accettura, Caterina; Frassineti, Giovanni Luca; Amadori, Dino; Nanni, Oriana

doi:10.25384/SAGE.12707217.v1

Suppl_stat_methods_ID_TAM-19-09-430_R1.pdf (90.77 kB)

Suppl_stat_methods_ID_TAM-19-09-430_R1 – Supplemental material for Effectiveness of bevacizumab in first- and second-line treatment for metastatic colorectal cancer: ITACa randomized trial

journal contribution

posted on 2020-07-24, 12:07 authored by Elisabetta Petracci, Emanuela Scarpi, Alessandro Passardi, Annibale Biggeri, Carlo Milandri, Stefano Vecchia, Fabio Gelsomino, Davide Tassinari, Stefano Tamberi, Ilaria Bernardini, Caterina Accettura, Giovanni Luca Frassineti, Dino Amadori, Oriana Nanni

Supplemental material, Suppl_stat_methods_ID_TAM-19-09-430_R1 for Effectiveness of bevacizumab in first- and second-line treatment for metastatic colorectal cancer: ITACa randomized trial by Elisabetta Petracci, Emanuela Scarpi, Alessandro Passardi, Annibale Biggeri, Carlo Milandri, Stefano Vecchia, Fabio Gelsomino, Davide Tassinari, Stefano Tamberi, Ilaria Bernardini, Caterina Accettura, Giovanni Luca Frassineti, Dino Amadori and Oriana Nanni in Therapeutic Advances in Medical Oncology